Viewing Study NCT01681368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-02-24 @ 5:08 AM
Study NCT ID: NCT01681368
Status: TERMINATED
Last Update Posted: 2017-05-30
First Post: 2012-09-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Ovarian Cancer View
None Peritoneal Neoplasms View
None Fallopian Tube Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NF-Kappa B Pathway View
None Response Biomarkers View
None Progression-Free Survival View
None Pharmacokinetics View
None Pharmacodynamics View